Stay updated on Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.

Latest updates to the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page
- Check4 days agoChange DetectedRemoved a general government funding lapse notice from the page; this removal does not alter study details, eligibility criteria, or trial procedures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedNo significant changes were detected; the Study Details page content and structure appear unchanged between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check46 days agoChange DetectedCore page content updated with a government operating-status notice and a version upgrade to v3.2.0; a specific resource reference (Carcinoma of esophagus) was removed.SummaryDifference2%

- Check54 days agoChange DetectedThe page now references revision v3.1.0 instead of v3.0.2, indicating an update to the version metadata. No other substantive content changes are indicated.SummaryDifference0.0%

- Check68 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2. The 'Back to Top' link was removed, a minor navigational change.SummaryDifference0.1%

- Check75 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.1%

Stay in the know with updates to Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.